The results showed that treatment with Ferr-1 restored the viability of NeuroD1-knocked down HCC-LM3 cells more significant than treatment with Z-VAD, while treatment with both of them restored the viability of these cells to a level similar to that of control (Fig 1J). The gene discussed is NEUROD1; the disease is hepatocellular carcinoma.